Unique ID issued by UMIN | UMIN000055007 |
---|---|
Receipt number | R000062749 |
Scientific Title | Association between Fetuin-A Fragment and Diabetic Kidney Disease in the Japanese Population |
Date of disclosure of the study information | 2024/07/18 |
Last modified on | 2024/07/18 10:03:23 |
Association between Fetuin-A Fragment and Diabetic Kidney Disease in the Japanese Population
Association between Fetuin-A Fragment and Diabetic Kidney Disease in the Japanese Population
Association between Fetuin-A Fragment and Diabetic Kidney Disease in the Japanese Population
Association between Fetuin-A Fragment and Diabetic Kidney Disease in the Japanese Population
Japan |
Diabetic Kidney disease
Nephrology |
Others
NO
Analysis of the association between Fetuin-A fragment and the development of diabetes-related kidney disease
Efficacy
Fetuin-A Fragment
eGFR
Albumin
Creatinine
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Patients aged 18 years and older at the time of obtaining consent.
Patients who, prior to the initiation of the observational study, received a thorough explanation from the principal investigator or the responsible physician (referred to as "attending physician") about the purpose, content, and anticipated secondary effects of the study, and who, after a comprehensive understanding, voluntarily agreed to participate in the observational study and provided written consent for participation.
Patients for whom written consent for participation in the study has been obtained personally.
Patients diagnosed with dementia.
Patients with Type 1 diabetes, pregnant individuals, malignancies, and those suffering from chronic/acute infections.
Patients with acute conditions requiring emergency intervention.
Patients who have shown primary or secondary kidney disorders or symptoms prior to diabetes diagnosis.
Patients diagnosed with alcohol or substance abuse within 3 months before signing the consent form.
Patients whom the attending physician has deemed inappropriate for participation in the study.
200
1st name | Hiroyuki |
Middle name | None |
Last name | Ito |
Edogawa Hospital
Department of Diabetes, Metabolism, and Nephrology
133-0052
2-24-18 Higashi-Koiwa, Edogawa-ku, Tokyo ,Japan
03-3673-4892
ito@edogawa.or.jp
1st name | Tomohiro |
Middle name | None |
Last name | Maruta |
Premedica Inc.
Overseas Sales & Marketing Division
105-0011
Terada Bldg. 5F, 2-3-3, Shibakoen, Minato-ku, Tokyo
03-5776-1105
tomohiro.maruta@premedica.co.jp
Edogawa Hospital
Premedica Inc.
Profit organization
Premedica Inc.
Terada Bldg. 5F, 2-3-3, Shibakoen, Minato-ku, Tokyo
03-5776-1105
tomohiro.maruta@premedica.co.jp
NO
2024 | Year | 07 | Month | 18 | Day |
Unpublished
200
No longer recruiting
2023 | Year | 07 | Month | 18 | Day |
2023 | Year | 08 | Month | 15 | Day |
2023 | Year | 09 | Month | 15 | Day |
2024 | Year | 09 | Month | 30 | Day |
None
2024 | Year | 07 | Month | 18 | Day |
2024 | Year | 07 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000062749
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |